Title : Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae.

Pub. Date : 2022 May

PMID : 35332581






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Herein, we rationally developed a nanoparticle vaccine, termed SCTV01B, by using the capsular polysaccharide of S. pneumoniae serotype 14 (PPS14) as the backbone to conjugate with the recombinant receptor binding domain (RBD) of the SARS-CoV-2 spike protein. Polysaccharides surface glycoprotein Severe acute respiratory syndrome coronavirus 2